Galimplant outlines European expansion plans

Dental Tribune International

Thu. 12. November 2026

save

Founded in 2007, Spanish dental implant manufacturer Galimplant is continuing its European expansion by establishing a presence in Belgium, the Netherlands and Luxembourg. At Dentex 2026, held in Belgium in October, the company presented its implant solutions alongside a programme of clinical lectures. Dental Tribune International spoke with two representatives involved in the company’s international expansion and two clinicians from its professional network about its growth plans, as well as clinical protocols and implant planning.

What is the company’s approach to entering new European markets?
Javier Acevedo Morales: Galimplant was founded by dentists for dentists and has become one of the main implant suppliers in Spain. The company has built strong relationships with universities and dental practices. We already have a presence in several international markets, including Croatia, Ecuador and Mexico, Portugal and the UAE, and we started operating in Belgium, the Netherlands and Luxembourg in April this year.

To introduce dentists who are not yet familiar with our brand to our products and the clinical approach behind our system, we are increasing our social media activities, but personal contact is equally important. We visit dentists individually to demonstrate our products and explain how the system works.

Our expansion strategy is based on three pillars: product quality, competitive pricing and professional education. We intend to develop courses, webinars and partnerships with universities to help clinicians learn to use the system.

Galimplant is also preparing to enter the UK market. What preparations are under way in this regard?
Dr Manuel Betoret Vila: Our UK company was officially established during the week of Dentex. At this stage, we are assessing the market and preparing for our UK launch at the BDIA Dental Showcase at ExCeL London next March.

Simplicity is central to Galimplant’s approach to implant treatment. How does this translate into clinical practice?
Dr Alberto Molina Palomero: Galimplant offers clinicians a simple, high-quality system at a competitive price. An important aspect of this approach is the one-abutment, one-time concept. Rather than repeatedly working directly at implant level, we use an intermediate abutment with the aim of reducing gingival inflammation and patient discomfort and maintaining the stability of both bone and soft tissue over time.

I have been working in Belgium for nearly 15 years, and part of my role here is to help clinicians become familiar with the products. We offer workshops and small-group training sessions in which dentists can learn how to use the system and apply this clinical approach for the benefit of their patients.

Prof. Peñarrocha Oltra, you have collaborated with Galimplant for approximately ten years. What has this collaboration involved?
Prof. David Peñarrocha Oltra: Our collaboration at the University of Valencia involves both clinical work and scientific research. Galimplant provides implants and prosthetic components, including abutments, and it also funds research, including microbiological and proteomic analyses.

In my view, abutment design plays an important role in clinical outcomes. A key aspect of Galimplant’s protocol is placing the implant below the crestal bone level rather than at bone level. We then use a transmucosal abutment whose shape and surface characteristics can be modified with the aim of reducing bacterial colonisation and promoting favourable peri-implant tissue integration. This is one of our main research areas, and we have published scientific papers on the subject.

For me, the priority is preventing peri-implant disease rather than treating it once it develops. This requires adequate bone and soft tissue, correct implant positioning and high-quality restorative materials. If there is insufficient bone or soft tissue, we need to address these deficiencies. The clinician’s knowledge and ability to apply the correct protocols are therefore fundamental to achieving favourable outcomes.

“Our expansion strategy is based on three pillars: product quality, competitive pricing and professional education.”—Javier Acevedo Morales, co-founder of Galimplant Benelux

How could Galimplant’s international expansion help make educational programmes more accessible to dentists outside Spain?
Prof. Peñarrocha Oltra: We have developed a strong training programme in implant dentistry in Spain, supported by considerable clinical experience and expertise. We hope to bring this education to other countries as Galimplant expands internationally.

I teach courses at the University of Valencia and have also provided training in Latin America. If there is sufficient interest, we can organise similar courses elsewhere. For example, with a group of ten to 12 dentists, it would be possible to arrange a course in another country.

How does Galimplant’s planning software support guided implant surgery, and in what clinical situations do you see the greatest benefits?
Dr Molina Palomero: Digital dentistry has evolved very rapidly in recent years, and Galimplant is continuously developing its digital solutions. The Galimplant 3D Exacto software, for example, allows us to plan implant placement and design surgical guides.

We can import CBCT data and STL files obtained from digital impressions and then match these datasets to plan implant placement and guided surgery. Depending on the clinical situation, we can use a surgical guide for the initial drilling step or adopt a fully guided approach.

I think that guided surgery offers important advantages in terms of precision and can make many procedures easier. This is particularly relevant in full-arch rehabilitation, where the positions and angulations of multiple implants must be coordinated with the planned prosthesis. It is also valuable when there is reduced bone volume or the proposed implant site is close to the roots of adjacent teeth.

In these situations, guided surgery can provide greater precision than free-hand placement. However, it requires experience. In experienced hands, it can make treatment faster, easier and more comfortable for patients.

Beyond its implant products, what clinical and technical support does Galimplant provide to help dentists use its system?
Acevedo Morales: We aim to help dentists understand the clinical approach behind the system, particularly the importance of bone regeneration and working with intermediate abutments rather than placing restorations directly on the implants. We offer complete packages containing the components needed for treatment, making the system easier for dentists to use. We also provide technical support and clinical assistance, including support during initial surgical procedures to help dentists become familiar with the system.

Editorial note:

More information about Galimplant’s activities in Belgium, the Netherlands and Luxembourg is available at galimplantbenelux.com.